[Role of proteolytic and treatment of nephritis].
D000328:Adult; D000686:Amyloidosis / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D000963:Antimetabolites / Q000627:therapeutic use; D002918:Chymotrypsin / Q000627:therapeutic use*; D005260:Female; D005921:Glomerulonephritis / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000201:enzymology / Q000209:etiology*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D011239:Prednisolone / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology; D014357:Trypsin / Q000097:blood*; D014361:Trypsin Inhibitors / Q000097:blood*
D000963:Antimetabolites; D014361:Trypsin Inhibitors; D011239:Prednisolone; D002918:Chymotrypsin; D014357:Trypsin
K voprosu o roli proteoliticheskikh fermentov v patogeneze i lechenii nefritov.